Status:
COMPLETED
Investigations of New Markers in Patients With Shock
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Shock State
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Shock is a severe deficiency in oxygen at the cell level which could lead to the death.The study was aimed at finding markers of treatment response in patients with shock, with a better accuracy than ...
Detailed Description
Shock is a severe deficiency in oxygen at the cell level which could lead to the death. The treatment strategy relies on the profile of plasma lactate level, which the kinetics and metabolism are inad...
Eligibility Criteria
Inclusion
- shock state defined by a rise of plasma lactate level (\> 2 mmol/L)and/or refractory low blood pressure in the volume expansion requiring an introduction of catecholamines
- admission in intensive care \< 6 hours
Exclusion
- Pregnancy
- presumed survival lower than 48 hours
- absence of central venous way and arterial catheter
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00919685
Start Date
May 1 2009
Last Update
August 29 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique-Hopitaux de Marseille
Marseille, France